Market Risers: PetroNeft Resources, Royal Dutch Shell, Smith & Nephew

Broker Ratings

Shares of PetroNeft Resources with EPIC code: LON:PTR has moved up 4.87% or 0.18 points throughout the session so far. Traders have so far held a positive outlook during the session. The period high has peaked at 3.99 and hitting a low of 3.7. The number of shares traded by this point in time totalled 922,343 with the daily average number around 747,820. A 52 week share price high is 4.7 some 0.9 points difference from the previous days close and putting the 52 week low at 0.5 which is a variance of 3.3 points. PetroNeft Resources has a 20 SMA of 3.79 and a 50 day moving average of 3.66. Market capitalisation for the company is £44.83m at the time of this report. The currency for this stock is Great British pence.Market cap is measured in GBP. This article was written with the last trade for PetroNeft Resources being recorded at Tuesday, September 28, 2021 at 1:12:20 PM GMT with the stock price trading at 3.99 GBX.

The trading price for Royal Dutch Shell with company EPIC: LON:RDSA has gained 3.73% or 59.6 points throughout today’s trading session so far. Market buyers have stayed positive during this period. The periods high has reached 1659 and a low of 1606.4. The total volume of shares exchanged so far has reached 3,357,216 while the daily average number of shares exchanged is 12,470,715. The 52 week high for the share price is 1659 amounting to 61.4 points difference from the previous close and the 52 week low at 878.1 which is a difference of 719.5 points. Royal Dutch Shell now has a 20 moving average of 1478.06 with a 50 day MA at 1459.38. The market cap now stands at £150,547.77m at the time of this report. All share prices mentioned for this stock are traded in GBX. Mcap is measured in GBP. This article was written with the last trade for Royal Dutch Shell being recorded at Tuesday, September 28, 2021 at 1:31:23 PM GMT with the stock price trading at 1657.2 GBX.

Shares of Smith & Nephew EPIC code: LON:SN has stepped up 1.07% or 14.17 points during today’s session so far. Market buyers have remained positive while the stock has been in play. The periods high has already touched 1344.5 dropping as low as 1318.5. The total volume of shares exchanged through this period comes to 535,664 with the average number of shares traded daily being 2,155,674. A 52 week share price high is 1681.5 around 351.5 points different to the previous business close and a 52 week low sitting at 1294 making a difference of 36 points. Smith & Nephew now has a 20 moving average of 1369.62 and now a 50 day MA at 1417.69. Market capitalisation for the company is £11,847.72m at the time of this report. The share price is in Great British pence. Mcap is measured in GBP. This article was written with the last trade for Smith & Nephew being recorded at Tuesday, September 28, 2021 at 1:30:48 PM GMT with the stock price trading at 1344.17 GBX.

Share on:
Find more news, interviews, share price & company profile here for:

Latest Company News

Smith & Nephew to host Capital Markets Days in London and New York

Smith & Nephew will hold Capital Markets Days on 8 December in London and 11 December in New York to outline its new strategy, mid-term priorities, and portfolio growth plans.

Smith & Nephew Plc delivers strong H1 with profit up 31%

Smith+Nephew reported 5.0% underlying revenue growth and a 30.6% rise in operating profit for H1 2025. EPS rose 36.6% to 33.5¢ and free cash flow surged to $244m. The company also announced a $500m share buyback for H2, supported by strong cash generation and margin expansion.

Smith & Nephew appoints David King as Non-Executive Director

Smith & Nephew Plc announces the addition of David King as an independent Non-Executive Director, effective July 1, 2025, enhancing their healthcare leadership.

Smith & Nephew Plc 12-Point Plan increasingly delivering better financial performance

Smith & Nephew reports strong financial results for 2024 with significant revenue and profit growth, driven by innovation and strategic restructuring.

Smith & Nephew Plc delivers Q3 revenue of $1,412 million, 4% growth

Smith & Nephew's Q3 2024 update shows a 4% revenue growth to $1,412M. Despite China headwinds, US Orthopaedics and Sports Medicine excelled.

Smith & Nephew Plc transforming into a higher growth and more profitable business

Smith & Nephew plc (LON:SN, NYSE:SNN) reports a robust financial performance for Q2 and H1 2024, showing significant revenue and profit growth.

Search

Search